REDAPT Anteverted Cemented Liner
K-Number: K160923 · 2016-11-17
Device Summary
Frequently Asked Questions
What is the REDAPT Anteverted Cemented Liner?
REDAPT Anteverted Cemented Liner is a medical device that received FDA 510(k) clearance on 2016-11-17. The listed applicant is Smith & Nephew, Inc.. The 510(k) number is K160923.
When did REDAPT Anteverted Cemented Liner receive FDA 510(k) clearance?
REDAPT Anteverted Cemented Liner received FDA 510(k) clearance on 2016-11-17, under 510(k) number K160923.
Who is the listed applicant for REDAPT Anteverted Cemented Liner?
The FDA 510(k) record lists Smith & Nephew, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for REDAPT Anteverted Cemented Liner?
The FDA product code for REDAPT Anteverted Cemented Liner is JDI.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Smith & Nephew, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: JDI)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.